Studies have shown that BRCA2-associated prostate tumors exhibit an aggressive phenotype and are often associated with the presence of the intraductal carcinoma of the prostate pathology, a poor prognostic feature for prostate cancer [8]. This evidence concerns the gene BRCA2 and prostate cancer.